Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
58.50
+1.30 (2.27%)
Feb 10, 2026, 11:32 AM CET
Infant Bacterial Therapeutics AB Employees
Infant Bacterial Therapeutics AB had 8 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
8
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-8.15M SEK
Market Cap
770.57M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 8 | 0 | - |
| Sep 30, 2024 | 10 | 2 | 25.00% |
| Jun 30, 2024 | 9 | 1 | 12.50% |
| Mar 31, 2024 | 8 | 0 | - |
| Dec 31, 2023 | 8 | 1 | 14.29% |
| Sep 30, 2023 | 8 | -2 | -20.00% |
| Jun 30, 2023 | 8 | 0 | - |
| Mar 31, 2023 | 8 | 0 | - |
| Dec 31, 2022 | 7 | -1 | -12.50% |
| Sep 30, 2022 | 10 | 2 | 25.00% |
| Jun 30, 2022 | 8 | 0 | - |
| Mar 31, 2022 | 8 | -1 | -11.11% |
| Dec 31, 2021 | 8 | -2 | -20.00% |
| Sep 30, 2021 | 8 | -2 | -20.00% |
| Jun 30, 2021 | 8 | -2 | -20.00% |
| Mar 31, 2021 | 9 | -1 | -10.00% |
| Dec 31, 2020 | 10 | 1 | 11.11% |
| Sep 30, 2020 | 10 | 0 | - |
| Jun 30, 2020 | 10 | 0 | - |
| Mar 31, 2020 | 10 | 2 | 25.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Oncopeptides AB | 75 |
| Genovis AB (publ.) | 36 |
| Mendus AB | 29 |
| Xspray Pharma AB | 26 |
| Cantargia AB | 23 |
| Intervacc AB | 15 |
| Corline Biomedical AB | 13 |
| Ascelia Pharma AB | 11 |